Network pharmacology revealed that some targets of Asp G overlapped with those in PD, and these shared targets are mainly involved in the IL-17 signaling pathway, TNF signaling pathway, leukocyte transendothelial migration, and focal adhesion. Here, IL17A is linked to Parkinson disease.